6 completed, 5 unknown, 1 active not recruiting, 1 terminated. 4 Phase 4, 3 Not applicable, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Not applicable | 3 | Unknown 3 |
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Bronchodilator Agents: new trials by email Literature Review of Bronchodilator Agents trials Research Report on Bronchodilator Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD Patients Control, NIMV group - Chronic Obstructive Pulmonary Disease, Hypercapnic | Phase 4 | Unknown | Hospital Universitario La Paz | 50 | 2025-12-01 | 2023-03-06 |
| Evaluating Bronchodilator Response in Patients With Bronchiectasis spirometry, Salbutamol, placebo - Bronchiectasis, Cystic Fibrosis | Not applicable | Unknown | Rambam Health Care Campus | 96 | 2023-05-20 | 2023-07-06 |
| Bronchodilators on the Exercise Capacity of Bronchiectasis Patients Bronchodilator (Ipratropium and Fenoterol), Placebo - Bronchiectasis Adult | Not applicable | Unknown | University of Sao Paulo General Hospital | 40 | 2022-04-14 | 2023-12-11 |
| Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial Salbutamol, Placebo - Wheezing | Phase 4 | Withdrawn | UMC Utrecht | 2021-09-01 | 2021-07-23 | |
| Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease Bronchodilator Agents - Pulmonary Disease, Chronic Obstructive | Phase 4 | Terminated | Università degli Studi di Ferrara | 843 | 2018-11-11 | 2022-12-28 |
| Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators Fentanyl Citrate, Combivent - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | Dr. Denis O'Donnell | 20 | 2017-09-20 | 2024-04-03 |
| Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD) Bronchodilators, Placebos - Chronic Obstructive Pulmonary Disease | Not applicable | Unknown | Laval University | 34 | 2017-04-13 | 2018-07-06 |
| Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters multiple-breath-washout test, Bronchodilator Agents - Obstructive Ventilation Disorders | Completed | Universitätsmedizin Mannheim | 145 | 2016-05-01 | 2019-01-02 | |
| A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma Beclomethasone dipropionate breath-actuated inhaler, Placebo breath-actuated inhaler, albuterol/salbutamol - Persistent Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 273 | 2013-12-26 | 2021-11-09 |
| A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma Beclomethasone dipropionate BAI, Placebo BAI, albuterol/salbutamol 90 mcg - Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 628 | 2013-12-01 | 2021-11-09 |
| A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma Beclomethasone dipropionate, Placebo, Albuterol/salbutamol - Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 1113 | 2013-12-01 | 2021-11-09 |
| Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia Pentostatin, Rituximab, Bendamustine - Hairy Cell Leukemia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 69 | 2010-07-01 | 2026-10-15 |
| Bronchoreversibility and Radiologic Morphology of Emphysema Bronchodilators - Emphysema, COPD | Unknown | University of Rome Tor Vergata | 60 | 2009-11-01 | 2013-12-11 | |
| Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics Bronchodilator - Asthma | Phase 2 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 2005-06-30 | 2021-12-08 |
Pulmonary Disease, Chronic Obstructive (5) · Asthma (4) · Bronchiectasis (2) · Bronchiolitis Obliterans (1) · Ciliary Motility Disorders (1) · Cystic Fibrosis (1) · Emphysema (1) · Hypercapnia (1) · Leukemia, Hairy Cell (1) · Motor Activity (1) · Neoplasm, Residual (1) · Primary Immunodeficiency Diseases (1) · Respiratory Sounds (1)
Teva Branded Pharmaceutical Products R&D, Inc. (4) · Dr. Denis O'Donnell (1) · Hospital Universitario La Paz (1) · Laval University (1) · National Cancer Institute (NCI) (1) · Rambam Health Care Campus (1) · UMC Utrecht (1) · University of Rome Tor Vergata (1) · University of Sao Paulo General Hospital (1) · Università degli Studi di Ferrara (1) · Universitätsmedizin Mannheim (1)
United States (5) · Canada (2) · Germany (2) · Italy (2) · Poland (2) · Brazil (1) · Croatia (1) · Hungary (1) · Israel (1) · Mexico (1) · Spain (1) · Ukraine (1)
Ann van den Bruel, Professor (1) · Celso RF Carvalho, PhD (1) · Denis E O'Donnell, MD, FRCPC (1) · Didier Saey, Ph.D. (1) · Eugenio Pompeo, MD (1) · Mordechai Pollak, MD, MSc (1) · Robert J Kreitman, M.D. (1)
PMID 27510595, PMID 28710850, PMID 28886758, PMID 40720815, PMID 41060318